ADAMTS5 and ovarian cancer: In another study, a higher ADAMTS-1, ADAMTS-5, aggrecan, versican and TIMP-3 expression in malignant ovarian tumors compared to benign tumors was associated with a shorter overall survival in ovarian cancer patients [227].